Cargando…
Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery
Most lysosomal storage disorders affect the central nervous system. However, lysosomal enzymes do not cross the blood-brain barrier (BBB), and intravenous enzyme infusion is not effective for the brain. Lysosomal enzymes can be re-engineered for BBB transport as IgG-enzyme fusion proteins, where the...
Autores principales: | Boado, Ruben J., Lu, Jeff Zhiqiang, Hui, Eric Ka-Wai, Lin, Huilan, Pardridge, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901507/ https://www.ncbi.nlm.nih.gov/pubmed/31819150 http://dx.doi.org/10.1038/s41598-019-55136-4 |
Ejemplares similares
-
IgG Fusion Proteins for Brain Delivery of Biologics via Blood–Brain Barrier Receptor-Mediated Transport
por: Boado, Ruben J.
Publicado: (2022) -
Insulin Receptor Antibody–Sulfamidase Fusion
Protein Penetrates the Primate Blood–Brain Barrier and Reduces
Glycosoaminoglycans in Sanfilippo Type A Cells
por: Boado, Ruben J., et al.
Publicado: (2014) -
Pharmacokinetics and Safety in Rhesus Monkeys of a Monoclonal Antibody-GDNF Fusion Protein for Targeted Blood-Brain Barrier Delivery
por: Pardridge, William M., et al.
Publicado: (2009) -
Treatment of CLN1 disease with a blood-brain barrier penetrating lysosomal enzyme
por: Hahn, Andreas, et al.
Publicado: (2022) -
Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)